AGP Picks
View all

Blue Echo Care adds three skin tag removal devices to Amazon Canada

10 hours ago
Blue Echo Care adds three skin tag removal devices to Amazon Canada
By AI, Created 05:56 UTC, Nov 09, 2026, AGP -

Blue Echo Care has launched three new skin tag removal devices for Canadian consumers through Amazon Canada, expanding its personal healthcare lineup. The move adds another product category to the company’s medical device portfolio as it continues to grow beyond respiratory care and monitoring tools.

Why it matters: - Blue Echo Care is moving further into consumer-facing personal healthcare, adding skin tag removal products to a portfolio that already spans respiratory care, oxygen therapy, patient monitoring, and therapeutic devices. - The launch gives Canadian shoppers another set of options in a common online marketplace for products tied to everyday skincare and minor personal healthcare needs. - Skin tags are usually benign, but consumers still need proper identification before trying to remove a growth.

What happened: - Blue Echo Care announced three new skin tag removal devices now available through Amazon Canada. - The products are BeC Medical-Grade Skin Tag Remover SKINTAG-01, SKINTAG-02 and SKINTAG-03. - The company said the launch expands its Canadian healthcare portfolio and broadens its personal healthcare and skincare offerings. - Founder and CEO Ed Wagner said the expansion reflects Blue Echo Care’s goal of making healthcare technologies more accessible to Canadian consumers.

The details: - The products are listed for sale through Amazon Canada, with individual product pages for specifications, availability, instructions and purchasing information. - The Amazon links are SKINTAG-01, SKINTAG-02 and SKINTAG-03. - Blue Echo Care describes skin tags, medically known as acrochordons, as common, typically benign growths that can appear where skin rubs, including the neck, underarms and skin folds. - The company says people may seek removal for cosmetic reasons or because the growths get irritated by clothing or jewelry. - Blue Echo Care says consumers should consult a qualified healthcare professional if a growth is uncertain, changing, bleeding or otherwise concerning. - The company was founded in 2018. - Blue Echo Care operates under an ISO 13485-certified quality management system and holds Medical Device Single Audit Program certification. - Blue Echo Care says those systems support regulatory compliance, supplier oversight, product documentation and quality assurance. - The company’s existing portfolio includes respiratory care equipment, oxygen therapy products, patient monitoring technologies, therapeutic devices and other medical equipment. - Blue Echo Care says product-specific regulatory requirements and authorized indications are reviewed separately under the applicable Canadian regulatory framework.

Between the lines: - The launch suggests Blue Echo Care is leaning on online distribution and familiar consumer marketplaces to reach more buyers without changing its core medical-device model. - Releasing three products at once signals a portfolio strategy focused on giving consumers multiple options within one category rather than testing a single SKU. - The move also reflects broader consumer interest in personal healthcare products that can be researched and compared online before purchase.

What's next: - Blue Echo Care says it will continue evaluating additional healthcare technologies across respiratory care, personal health monitoring, therapeutic applications and consumer-oriented medical devices. - The company plans to keep expanding its Canadian product portfolio while maintaining its quality systems and regulatory processes. - Consumers can find more information about Blue Echo Care and its product line on the company's website: More information.

The bottom line: - Blue Echo Care is broadening its Canadian product lineup with three new skin tag removal devices, using Amazon Canada as the main sales channel and regulatory-quality credentials as part of its pitch.

Disclaimer: This article was produced by AGP Wire with the assistance of artificial intelligence based on original source content and has been refined to improve clarity, structure, and readability. This content is provided on an “as is” basis. While care has been taken in its preparation, it may contain inaccuracies or omissions, and readers should consult the original source and independently verify key information where appropriate. This content is for informational purposes only and does not constitute legal, financial, investment, or other professional advice.

Sign up for:

Canadian Health Industry News

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.

Share this page:

Advanced Search Options

Search for:

Search scope:

Type:

Search in:

Date range:

The last

Sort by:

Sign up for:

Canadian Health Industry News

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.